DOM-1112

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameDOM-1112

Drug Alias Namedomain antibody therapy (Domantis)dual-targeting dAb conjugate (Domantis)DOM-1112

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment +[4]

Mechanisms of ActionLymphocyte differentiation antigen CD38 inhibitorsSyndecan-1 inhibitors

TargetsLymphocyte differentiation antigen CD38Syndecan-1

Therapy Area/IndicationsMultiple Myeloma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesDomantis Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesDomantis Ltd

Active IndicationsN/A

Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A